tiprankstipranks
Trending News
More News >
Clal Insurance Enterprises Holdings Limited (IL:CLIS)
:CLIS
Israel Market

Clal Insurance (CLIS) AI Stock Analysis

Compare
0 Followers

Top Page

IL:CLIS

Clal Insurance

(CLIS)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 4o)
Rating:75Outperform
Price Target:
21,787.00
▲(1.90% Upside)
Clal Insurance's strong financial performance and reasonable valuation are the primary drivers of its score. The stock's bullish technical indicators are tempered by overbought signals, suggesting caution. The absence of earnings call and corporate events data limits further insights.
Positive Factors
Revenue Growth
Strong revenue growth indicates effective market strategies and product offerings, enhancing long-term business sustainability.
Cash Flow Improvements
Improving cash flow enhances financial flexibility, allowing for strategic investments and debt management, supporting long-term growth.
Profitability
High profitability margins reflect efficient operations and cost management, contributing to sustained financial health and competitive positioning.
Negative Factors
High Leverage
Significant leverage can increase financial risk, especially in volatile markets, potentially impacting long-term stability and investment capacity.
Net Profit Margin
While improved, the net profit margin indicates potential for better cost management, crucial for enhancing profitability and shareholder value.
Operating Cash Flow Data Gaps
Lack of detailed operating cash flow data limits full assessment of cash flow efficiency, potentially obscuring financial health insights.

Clal Insurance (CLIS) vs. iShares MSCI Israel ETF (EIS)

Clal Insurance Business Overview & Revenue Model

Company DescriptionClal Insurance Enterprises Holdings Ltd. provides insurance services in Israel. It operates through three segments: Long-Term Savings, Non-Life insurance, and Health Insurance. The Long-Term Savings segment offers life insurance products and accompanying coverages; long-term savings for various insurance policies, and pension and provident funds, including study funds; and insurance coverage for various risks, such as death, disability, loss of working capacity, and health insurance policies. The Non-life Insurance segment offers third party, employers', professional, and product liability insurance products; credit and foreign trade risks; and property, motor, personal accident, and other insurance products, as well as guarantees. The Health Insurance segment provides long-term care, medical expenses, surgeries, transplants, personal accidents, international travel, dental, foreign workers, and other insurance products. Clal Insurance Enterprises Holdings Ltd. was incorporated in 1987 and is based in Tel Aviv-Yafo, Israel.
How the Company Makes MoneyClal Insurance generates revenue primarily through the collection of premiums from its various insurance products, including life, health, and property insurance. The company earns money by underwriting insurance policies, where it assesses risk and sets premium rates accordingly. Additionally, Clal Insurance invests the premiums it collects into various financial markets, generating investment income. Key revenue streams include individual policyholder premiums, group insurance contracts, and investment returns from the managed assets within its portfolio. The company may also engage in strategic partnerships with financial institutions and other entities to offer bundled services, enhancing its market reach and revenue potential.

Clal Insurance Financial Statement Overview

Summary
Clal Insurance shows strong revenue growth and profitability, with effective cost management and operational efficiency. However, the high debt-to-equity ratio indicates significant leverage, which could pose risks. Cash flow improvements are notable, enhancing financial flexibility, but further optimization is needed.
Income Statement
85
Very Positive
Clal Insurance demonstrates robust revenue growth with a 23.84% increase in TTM, indicating strong market performance. The company maintains healthy profitability with a gross profit margin exceeding 100% and a net profit margin of 5.09%. EBIT and EBITDA margins are also solid at 10.41% and 12.21%, respectively, reflecting efficient operations. However, the net profit margin, while improved, suggests room for further enhancement in cost management.
Balance Sheet
70
Positive
The balance sheet shows a high debt-to-equity ratio of 1.66, indicating significant leverage, which could pose risks in volatile markets. However, the return on equity is strong at 15.13%, showcasing effective use of equity to generate profits. The equity ratio is not provided, but the company's substantial total assets suggest a stable asset base.
Cash Flow
78
Positive
Clal Insurance's cash flow is improving, with a significant 56.32% growth in free cash flow, indicating enhanced cash generation capabilities. The free cash flow to net income ratio of 76.43% suggests effective conversion of profits into cash. However, the operating cash flow to net income ratio is unavailable, which limits a full assessment of cash flow efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue27.98B26.83B21.45B7.31B25.06B14.64B
Gross Profit27.23B25.93B20.43B6.11B24.00B13.60B
EBITDA3.38B2.33B1.46B729.00M2.14B1.07B
Net Income1.41B718.00M220.00M121.00M1.08B438.68M
Balance Sheet
Total Assets178.97B170.10B163.62B144.62B145.51B124.48B
Cash, Cash Equivalents and Short-Term Investments7.06B20.15B8.64B13.90B26.53B17.72B
Total Debt15.72B775.00M777.00M5.13B4.86B4.64B
Total Liabilities169.40B160.57B154.97B136.56B137.73B118.13B
Stockholders Equity9.49B9.45B8.58B8.00B7.72B6.30B
Cash Flow
Free Cash Flow1.35B1.32B-4.64B-2.80B6.87B-1.47B
Operating Cash Flow1.76B1.38B-4.31B-2.59B7.09B-1.25B
Investing Cash Flow-2.32B-1.08B-2.24B-365.96M-162.00M-379.62M
Financing Cash Flow443.00M-79.00M1.44B785.33M16.00M-194.31M

Clal Insurance Technical Analysis

Technical Analysis Sentiment
Positive
Last Price21380.00
Price Trends
50DMA
18664.80
Positive
100DMA
17548.40
Positive
200DMA
14169.93
Positive
Market Momentum
MACD
522.86
Negative
RSI
65.47
Neutral
STOCH
95.39
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:CLIS, the sentiment is Positive. The current price of 21380 is above the 20-day moving average (MA) of 20069.50, above the 50-day MA of 18664.80, and above the 200-day MA of 14169.93, indicating a bullish trend. The MACD of 522.86 indicates Negative momentum. The RSI at 65.47 is Neutral, neither overbought nor oversold. The STOCH value of 95.39 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:CLIS.

Clal Insurance Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
32.94B12.094.21%12.22%71.58%
79
Outperform
20.56B12.302.78%23.28%124.99%
76
Outperform
$23.84B12.3623.23%2.27%5.84%138.80%
75
Outperform
14.81B10.421.76%-27.87%229.49%
70
Outperform
12.79B14.560.34%6.00%36.33%
69
Neutral
3.55B10.316.32%19.48%53.61%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:CLIS
Clal Insurance
21,380.00
12,974.51
154.36%
IL:HARL
Harel
13,860.00
8,966.73
183.25%
IL:MGDL
Migdal Insur.
1,518.00
844.00
125.22%
IL:PHOE
Phoenix
14,230.00
9,322.17
189.94%
IL:MMHD
Menora Miv Hld
41,250.00
27,205.59
193.71%
IL:IDIN
Idi Insur
25,180.00
13,033.09
107.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025